Vascular oxidative stress causes neutrophil arrest in brain capillaries, leading to decreased cerebral blood flow and contributing to memory impairment in a mouse model of Alzheimer’s disease
暂无分享,去创建一个
C. Iadecola | N. Nishimura | C. Schaffer | J. Xiang | David Xiang | L. Park | A. Tan | Muhammad Ali | K. Falkenhain | Brendah N. Njiru | Nancy Ruiz-Uribe | Mohammad Haft-Javaherian | O. Bracko | T. Sanchez | Hiroki Uchida | Sabyasachi Dash | Madisen A Swallow | Argen Omurzakov | Michael E. Lamont | Hsin-Yun Chang | Nancy E Ruiz-Uribe | Laibaik Park | J. Xiang
[1] T. Shekh-Ahmad,et al. Specific inhibition of NADPH oxidase 2 modifies chronic epilepsy , 2022, Redox biology.
[2] D. Drachman,et al. Cumulative effect of simvastatin, l-arginine, and tetrahydrobiopterin on cerebral blood flow and cognitive function in Alzheimer’s disease , 2022, Alzheimer's Research & Therapy.
[3] K. Arai,et al. Effects of cerebral amyloid angiopathy on the brain vasculome , 2022, Aging cell.
[4] A. Fagan,et al. Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease , 2022, Neurology: Neuroimmunology & Neuroinflammation.
[5] N. Nishimura,et al. VEGF signalling causes stalls in brain capillaries and reduces cerebral blood flow in Alzheimer’s mice , 2022, Brain : a journal of neurology.
[6] A. Hainsworth,et al. Vascular cognitive impairment and dementia: An early career researcher perspective , 2022, Alzheimer's & dementia.
[7] C. Iadecola,et al. Revisiting the neurovascular unit , 2021, Nature Neuroscience.
[8] Y. Kulkarni,et al. Pharmacology of apocynin: a natural acetophenone , 2021, Drug metabolism reviews.
[9] H. Potter,et al. Astrogliosis and episodic memory in late life: higher GFAP is related to worse memory and white matter microstructure in healthy aging and Alzheimer's disease , 2021, Neurobiology of Aging.
[10] K. Blennow,et al. Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease , 2020, Translational Psychiatry.
[11] David A Hartmann,et al. Brain capillary pericytes exert a substantial but slow influence on blood flow , 2020, Nature Neuroscience.
[12] Nancy Ruiz-Uribe,et al. Brain and blood extraction for immunostaining, protein, and RNA measurements after long-term two photon imaging in mice. , 2020 .
[13] Yun-Kyoung Lee,et al. The isolation and molecular characterization of cerebral microvessels , 2019, Nature Protocols.
[14] G. Douglas,et al. Nox2 contributes to age-related oxidative damage to neurons and the cerebral vasculature , 2019, The Journal of clinical investigation.
[15] D. Attwell,et al. Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes , 2019, Science.
[16] R. Kievit,et al. MICROGLIAL ACTIVATION AND TAU BURDEN PREDICT COGNITIVE DECLINE IN ALZHEIMER’S DISEASE , 2019, Alzheimer's & Dementia.
[17] Chris B. Schaffer,et al. Increasing cerebral blood flow improves cognition into late stages in Alzheimer’s disease mice , 2019, bioRxiv.
[18] S. Quake,et al. Aged blood impairs hippocampal neural precursor activity and activates microglia via brain endothelial cell VCAM1 , 2019, Nature Medicine.
[19] John X. Morris,et al. Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction , 2018, Nature Medicine.
[20] Myriam Peyrounette,et al. Neutrophil adhesion in brain capillaries reduces cortical blood flow and impairs memory function in Alzheimer’s disease mouse models , 2018, Nature Neuroscience.
[21] T. Deierborg,et al. Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response , 2018, Front. Cell. Neurosci..
[22] Eun Woo Son,et al. iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data , 2018, BMC Bioinformatics.
[23] C. Claudianos,et al. Brain Energy and Oxygen Metabolism: Emerging Role in Normal Function and Disease , 2018, Front. Mol. Neurosci..
[24] Ya-Ting Chang,et al. Cerebral Perfusion Insufficiency and Relationships with Cognitive Deficits in Alzheimer’s Disease: A Multiparametric Neuroimaging Study , 2018, Scientific Reports.
[25] Arne Møller,et al. Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease , 2017, Alzheimer's & Dementia.
[26] Axel Montagne,et al. Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease , 2017, Nature Reviews Neuroscience.
[27] A. Heerschap,et al. Hypertension, cerebrovascular impairment, and cognitive decline in aged AβPP/PS1 mice , 2017, Theranostics.
[28] S. Cuzzocrea,et al. FeTPPS Reduces Secondary Damage and Improves Neurobehavioral Functions after Traumatic Brain Injury , 2017, Front. Neurosci..
[29] B. Stoica,et al. Microglial/Macrophage Polarization Dynamics following Traumatic Brain Injury. , 2016, Journal of neurotrauma.
[30] Gary D. Bader,et al. AutoAnnotate: A Cytoscape app for summarizing networks with semantic annotations , 2016, F1000Research.
[31] Norbert Schuff,et al. Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis , 2016, Nature Communications.
[32] G. Wang,et al. Endothelial Dysfunction and Amyloid-β-Induced Neurovascular Alterations , 2016, Cellular and Molecular Neurobiology.
[33] D. Catalucci,et al. Neutrophils promote Alzheimer's disease–like pathology and cognitive decline via LFA-1 integrin , 2015, Nature Medicine.
[34] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[35] C. Iadecola,et al. The key role of transient receptor potential melastatin-2 channels in amyloid-β-induced neurovascular dysfunction , 2014, Nature Communications.
[36] Norbert Schuff,et al. Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment. , 2014, Brain : a journal of neurology.
[37] D. Attwell,et al. Capillary pericytes regulate cerebral blood flow in health and disease , 2014, Nature.
[38] Alin Ciobica,et al. The oxidative stress hypothesis in Alzheimer's disease. , 2013, Psychiatria Danubina.
[39] C. Iadecola,et al. The Pathobiology of Vascular Dementia , 2013, Neuron.
[40] B. Winblad,et al. Diabetes, Alzheimer disease, and vascular dementia A population-based neuropathologic study , 2013 .
[41] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[42] Sung-Ho Han,et al. Dynamic Optical Imaging of Metabolic and NADPH Oxidase-Derived Superoxide in Live Mouse Brain Using Fluorescence Lifetime Unmixing , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[43] M. Beal,et al. Neuroprotective strategies involving ROS in Alzheimer disease. , 2011, Free radical biology & medicine.
[44] Marcel Martin. Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .
[45] C. Iadecola,et al. Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-β , 2011, Proceedings of the National Academy of Sciences.
[46] D. Attwell,et al. Glial and neuronal control of brain blood flow , 2022 .
[47] J. C. de la Torre. Vascular risk factor detection and control may prevent Alzheimer's disease. , 2010, Ageing research reviews.
[48] M. Kivipelto,et al. Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention , 2009, Dialogues in clinical neuroscience.
[49] C. Szabó,et al. Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. , 2008, The American journal of pathology.
[50] Ping Zhou,et al. Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein , 2008, Proceedings of the National Academy of Sciences.
[51] Shi-Jiang Li,et al. Perfusion fMRI detects deficits in regional CBF during memory-encoding tasks in MCI subjects , 2007, Neurology.
[52] K. Baer,et al. Immunohistochemical staining of post-mortem adult human brain sections , 2006, Nature Protocols.
[53] C. Iadecola,et al. Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. , 2006, Journal of applied physiology.
[54] Houeto Jean-Luc. [Parkinson's disease]. , 2022, La Revue du praticien.
[55] S. Koh,et al. Effect of 3-aminobenzamide, PARP inhibitor, on matrix metalloproteinase-9 level in plasma and brain of ischemic stroke model. , 2005, Toxicology.
[56] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[57] Xunbin Wei,et al. In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment , 2005, Nature.
[58] Ping Zhou,et al. NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide. , 2005, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[59] B. Hyman,et al. Imaging Aβ Plaques in Living Transgenic Mice with Multiphoton Microscopy and Methoxy‐X04, a Systemically Administered Congo Red Derivative , 2002, Journal of neuropathology and experimental neurology.
[60] F. Rey,et al. Novel Competitive Inhibitor of NAD(P)H Oxidase Assembly Attenuates Vascular O2− and Systolic Blood Pressure in Mice , 2001, Circulation research.
[61] C. Iadecola,et al. Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[62] D. Borchelt,et al. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein , 1999, Nature Neuroscience.
[63] Jack C. de la Torre,et al. Cerebromicrovascular Pathology in Alzheimer’s Disease Compared to Normal Aging , 1997 .
[64] W R Markesbery,et al. Oxidative stress hypothesis in Alzheimer's disease. , 1997, Free radical biology & medicine.